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Abstract
Background: Diabetes mellitus is a heterogeneous group of disorders characterized by abnormalities of carbohydrate, protein and lipid 
metabolism. Type 1 diabetes mellitus is an autoimmune disease caused by destruction of pancreatic beta cells and characterized by 
defect in insulin secretion while type 2 diabetes mellitus results from abnormalities in insulin secretion and/or insulin action or both.
Objectives: The present study was conducted to investigate the clinical hypoglycemic effects of Allium cepa in type 1 and type 2 
diabetic patients.
Results: In assessment of hypoglycaemic activity of Allium cepa in type 1 and type 2 diabetic patients, ingestion of crude Allium cepa 
(100 g) caused a considerable reduction in fasting blood glucose levels by about 89 mg/dl in relation to insulin (145 mg/dl) in type 
1 diabetic patients and it reduced fasting blood glucose levels by 40 mg/dl, compared to glibenclamide (81 mg/dl) in type 2 diabetic 
patients, 4 hours later. The same dose of crude Allium cepa produced a significant reduction in the induced hyperglycemia (GTT) by 
about 120 mg/dl compared to water (77 mg/dl) and insulin (153 mg/dl) in type 1 diabetic patients and considerably reduced GTT by 
159 mg/dl in relation to water (55 mg/dl) and glibenclamide (114 mg/dl) in type 2 diabetic patients, after 4 hours.
Conclusion: It was evident that, crude Allium cepa produced hypoglycemic effects, thus it could be used as a dietary supplement in 
management of type 1 and/or type 2 diabetes mellitus.
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Introduction
In  the  year  2000,  according  to  the  World  Health 
Organization, at least 170 million people worldwide 
(2.8% of the population) suffer from diabetes. Its inci-
dence is increasing rapidly, and it is estimated that 
by the year 2030, this number will almost double. 
Based on its etiology, diabetes mellitus is generally 
divided into three classifications: type 1, type 2 and 
gestational.1 Type 1 is an autoimmune disease char-
acterized by a defect in insulin secretion such that the 
pancreas produces little or no insulin. It occurs most 
often in children and young adults and accounts for 
5%–10% of cases of diabetes. Type 2 diabetes is a 
metabolic disorder characterized by a defect in insulin 
secretion  and/or  tissues  are  resistant  to  its  uptake. 
Type 2 accounts for 90%–95% of cases of diabetes.1,2 
The chronic hyperglycemia that characterizes diabetes 
mellitus results from either defects in insulin secretion 
or insulin action and/or both. When left unchecked, 
hyperglycemia precipitates micro and/or macrovascu-
lar complications including: cardiovascular disease, 
nephropathy, neuropathy, and retinopathy. Insulin and 
oral hypoglycemic agents are used in the management 
of type 1 and type 2 diabetes mellitus respectively.1,2
Medicinal plants continue to provide valuable thera-
peutic agents, in both modern medicine and traditional 
systems.3 Over four hundred traditional plant treatments 
for diabetes have been reported, although a small number 
of these have received scientific and medical evaluation 
to assess their efficacy and safety.4,5 Of these, ginseng 
species, Momordica Charantia (Bitter Melon), cloves, 
cinnamon, Trigonella foenum graecum (Fenugreek) and 
Allium cepa (onion) have been used for taste and flavour 
development in food preparations.5,6
The  use  of  plants  especially  vegetables  by  the 
population as antidiabetic remedies have added interest 
of joining two basic diabetes mellitus control factors: 
food and medication.5–8 Allium species such as onion 
has attracted particular attention of modern medicine 
because of its widespread health use around the world, 
and  the  cherished  belief  that  it  helps  in  maintaining 
good health, warding off illnesses and providing vig-
or.4 Onion is rich in flavonoids such as quercetin and 
sulphur compounds, such as cysteine and allyl propyl 
disulphide that have perceived benefits to human health. 
These  compounds  possess  antidiabetic,  antibiotic, 
hypocholesterolaemic,  fibrinolytic,  and  other  various 
beneficial biological effects.9,10 The present study was 
conducted  to  investigate  the  clinical  hypoglycemic 
effects of Allium cepa in type 1 and type 2 diabetic 
patients.
Materials and Methods
Plant material
Fresh and recently cropped Allium cepa harvested at 
the optimal maturity was purchased from the local 
market in Wad Medani city, Central Sudan. The fresh 
onion was cut into small slices to be taken orally by 
type 1 and type 2 diabetic patients.
criteria for selecting patients
For patients with type 1 and/or type 2 diabetes mellitus, 
the following criteria of selection were considered: 
age #50 years (mean 44 ± 3.87), the duration of dia-
betes was between 2–5 years, not taking medicines 
for other health condition, not taking vitamins or other 
supplements, not smoking or consuming alcohol and 
not suffering from any of diabetes complications.
Determination of fasting blood glucose 
levels and glucose tolerance tests  
in type 1 and type 2 diabetic patients
Two groups of type 1 and two groups of type 2 diabetic 
patients of both sexes were used in these clinical trials 
Table 1. Fasting blood glucose levels in type 1 diabetic patients receiving water (5 ml), insulin (5 IU/prescribed dose) and 
Allium cepa (100 g).
preparations Blood glucose level (mg/dL, mean ± s.e.M) 
normal range 80–120 mg/dl13
P value
0 h 1 h 2 h 4 h
Water 266 ± 7.22 254.33 ± 7.68 236 ± 8.39 211 ± 11.85 0.03
Insulin 243 ± 8.08 204 ± 8.72 165 ± 4.583 98.67 ± 2.90 0.001
Allium cepa 232 ± 7.72 241 ± 10.045 198.25 ± 14.64 143.38 ± 14.182 0.005Preliminary study of the clinical hypoglycemic effects of allium cepa
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to assess the hypoglycaemic effects of Allium cepa. For 
the two groups (I, II) of type 1 diabetic patients, the par-
ticipants of group I (n = 21) and group II (n = 21) were 
subjected to fasting blood glucose levels determination 
and glucose tolerance tests respectively. The two groups 
were subdivided into six subgroups (Ia, Ib, Ic and IIa, IIb, 
IIc) each consisted of seven registered patients (2 females 
and 5 males). Participants of the subgroups Ia, Ib and Ic 
were used for determination of fasting blood glucose 
levels while those of IIa, IIb and IIc were subjected to 
glucose tolerance tests after induction of hyperglycemia 
by administration of 75 g dextrose orally. The partici-
pants of subgroups Ia and IIa received water (negative 
control), while those of subgroup Ib and IIb (positive 
control) were administered standard treatment of insu-
lin (5 IU/prescribed doses and glibenclamide 5 mg/kg) 
respectively and those comprising subgroup Ic and IIc 
received 100 g of the crude fresh slices of Allium cepa 
as test groups (equivalent to 20 g dry drug).11 The par-
ticipants received the tested materials in the morning at 
8 am. Fasting blood glucose levels and glucose tolerance 
tests were determined at 0, 1, 2 and 4 hours using an 
  electronic glucometer (Tables 1 and 2; Figs. 1 and 2).
The other two groups (III, IV) of type 2 diabetic 
patients were tested to evaluate the hypoglycemic 
effects of Allium cepa. The participants of group III 
(n = 21) and group IV (n = 21) were subjected to 
fasting blood glucose levels determination and glu-
cose  tolerance  tests  respectively.  The  two  groups 
were subdivided into six subgroups (IIIa, IIIb, IIIc 
and IVa, IVb, IVc) each consisted of seven registered 
patients. Participants of the subgroup IIIa, IIIb and 
IIIc  were  used  for  determination  of  fasting  blood 
glucose levels while those of IVa, IVb and IVc were 
subjected to glucose tolerance tests after induction 
of hyperglycemia by administration of 75 g dextrose 
orally.  The  participants  of  subgroup  IIIa  and  IVa 
received water (negative control), subgroup IIIb and 
IVb were considered as positive control groups and 
administered  standard  treatment  of  glibenclamide 
Table 2. glucose tolerance tests in type 1 diabetic patients receiving water (5 ml), insulin (prescribed doses) and Allium 
cepa (100 g).
preparations Blood glucose level (mg/dL, mean ± s.e.M) 
normal range 80–120 mg/dl13
P value
0 h 1 h 2 h 4 h
Water 259 ± 17.12 405 ± 16.34 368.5 ± 15.11 328 ± 14.33 0.03
Insulin 205 ± 21.37 304.33 ± 16.19 208 ± 24.269 152.67 ± 15.69 0.001
Allium cepa 291 ± 14.48 398.8 ± 14.23 328.6 ± 13.47 278.2 ± 16.04 0.004
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Figure 1. Fasting blood glucose levels in type 1 diabetic patients receiving water (5 ml), insulin (5 IU/prescribed dose) and Allium cepa (100 g).Taj Eldin et al
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Table 3. Fasting blood glucose levels in type 2 diabetic patients receiving water (5 ml), glibenclamide (5 mg) and Allium 
cepa (100 g).
preparations Blood glucose level (mg/dL, mean ± s.e.M) 
normal range 80–120 mg/dl13
P value
0 h 1 h 2 h 4 h
Water 164.33 ± 18.5 175 ± 22.26 162.33 ± 19.1 148.67 ± 8.67 0.001
glibenclamide 181 ± 11.71 157.5 ± 11.25 131 ± 7.5 100.38 ± 6.41 0.003
Allium cepa 155 ± 25.29 165 ± 26.41 150.25 ± 17.73 115.5 ± 15.46 0.005
(5 mg/day) and those comprising subgroup IIIc and 
IVc were received 100 g of the crude fresh slices of 
Allium cepa as investigational (test) groups. Fast-
ing blood glucose levels and glucose tolerance tests 
were determined at 0, 1, 2 and 4 hours (Tables 3 and 
4; Figs. 3 and 4).
Ethical approval
The ethical approval for this study was obtained from 
the  Ethical  Committee/University  of  Gezira/Gezira 
State,  Ministry  of  Health,  Wad  Medani-Sudan. 
Consent  forms  were  signed  by  participants,  being 
interested in joining the study completely voluntary.
Statistical analysis
All the data were expressed as means ± standard error 
of means (SEM) and analyzed by analysis of variance 
(ANOVA). Comparisons with the control groups were 
made using One-way ANOVA. Differences were con-
sidered significant if P , 0.05.
Results and Discussion
Determination of fasting blood glucose 
levels and glucose tolerance tests  
in type 1 diabetic patients
Results obtained are shown in Table 1; Figure 1. For 
group 1 diabetic patients with type 1 diabetes mel-
litus, the fasting blood glucose levels in the tested 
patients ranged between 232 and 266 mg/dl. The 
blood glucose values in the negative control sub-
group Ia did not show much variations and the slight 
reduction in the blood glucose levels could be attrib-
uted to fasting. After the administration of insulin 
(5 IU/prescribed dose) a significant reduction in the 
fasting blood glucose levels in subgroup Ib (positive 
control) by 145 mg/dl was observed 4 hours later. 
While  the  administration  of  Allium  cepa  (100  g) 
caused  a  considerably  lowered  value  in  the  fast-
ing blood glucose levels in subgroup Ic of diabetic 
patients (test group) by about 89 mg/dl after 4 hours 
compared to reduction caused by water and insulin. 
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Figure 2. glucose tolerance test curves in type 1 diabetic patients receiving water (5 ml), insulin (prescribed doses) and Allium cepa (100 g).Preliminary study of the clinical hypoglycemic effects of allium cepa
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Such effect was also evidently noted in a previous 
clinical study where the juice of Allium cepa was 
administered orally to diabetic patients despite the 
low dose (50 mg) taken by them.12
For group II of type 1 diabetic patients (subgroup 
IIa, IIb, and IIc) blood glucose levels were determined 
at 0, 1, 2, and 4 hours using electronic glucometer. 
Results obtained showed that the administration of 
75 g dextrose caused high increase in the blood glucose 
levels in the three subgroups after the first hour rep-
resented by hyperglycaemic peak (Fig. 2). It has been 
also observed that the administration of Allium cepa 
produced a significant (P = 0.004) reduction in the 
induced hyperglycemia by about 120 mg/dl in rela-
tion to water (77 mg/dl) and the standard drug insu-
lin (152 mg/dl) four hours later. While for the same 
period of time the effect of the oral administration of 
Allium cepa demonstrated a relatively slight and grad-
ual decrease in fasting blood glucose levels compared 
to insulin (Table 2 and Fig. 2) and as shown in a simi-
lar clinical study performed by Shukia et al, (2000) 
who described such a decrease in glucose-induced 
hyperglycemia in human adults.14
Determination of fasting blood glucose 
levels and glucose tolerance tests  
in type 2 diabetic patients
For  group  III  of  type  2  diabetic  patients  and  as 
shown in Table 3 and Figure 3 fasting blood glu-
cose levels were determined. The administration of 
100 g of crude Allium cepa markedly reduced the 
fasting blood glucose levels in subgroup IIIc dia-
betic patients (test group) by 40 mg/dl after 4 hours 
(P = 0.005).
The oral administration of glibenclamide (5 mg/
day)  produced  a  significant  reduction  in  fasting 
blood  glucose  levels  in  subgroup  IIIb  diabetic 
patients  by  about  81  mg/dl,  four  hours  later. As 
glibenclamide acts by direct induction of insulin 
release from the pancreatic beta cells, such a sig-
nificant reduction in glucose levels was virtually 
evident.15
Table 4. glucose tolerance test (gTT) in type 2 diabetic patients receiving water (5 ml), glibenclamide (5 mg) and Allium 
cepa (100 g).
preparations Glucose level (mg/dL, mean ± s.e.M) 
normal range 80–120 mg/dl13
P value
0 h 1 h 2 h 4 h
Water 190 ± 18.55 320 ± 22.26 290 ± 19.1 265 ± 8.67 0.004
glibenclamide 185.6 ± 25.29 277 ± 26.41 203.8 ± 17.73 163.2 ± 15.46 0.001
Allium cepa 204.63 ± 11.7 372.5 ± 11.25 249 ± 13.2 213 ± 14.11 0.002
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Figure 3. Fasting blood glucose levels in type 2 diabetic patients receiving water (5 ml), glibenclamide (5 mg) and Allium cepa (100 g).Taj Eldin et al
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Figure 4. glucose tolerance test curves in type 2 diabetic patients receiving water (5 ml), glibenclamide (5 mg) and Allium cepa (100 g).
The  hypoglycemic  activity  of  Allium  cepa  has 
been demonstrated in many clinical studies, present-
ing  that,  the  addition  of  raw  onion  to  the  diet  for 
non-in-sulin-dependent  diabetic  subjects  decreased 
the dose of antidiabetic medication required to con-
trol the disease.16 Moreover, it was worthy noted that 
oral  administration  of  Allium  cepa  crude  hydroal-
coholic  extract  in  animal  models  (alloxan-induced 
diabetic  rats)  produced  a  significant  hypoglycemic 
activity and favourable good health effects which may 
be most probably attributed to improvement and/or 
regeneration  of  pancreatic  beta-cells.17  Allium  cepa 
acts as a hypoglycemic agent by mechanisms rather 
than increasing insulin levels having extra pancreatic 
effects; acting directly on tissues as liver, muscles etc. 
and alter the activities of the regulatory enzymes of 
glycolysis, gluconeogenesis and other pathways.14,16,18
In group IV of type 2 diabetic individuals it was 
noticed  that,  the  administration  of  75  g  dextrose 
caused an increase in the blood glucose levels in all 
subjects after one hour demonstrated by hyperglyce-
mic peak (Fig. 4). Among the three subgroups, those 
who had received Allium cepa showed the highest 
peak.  Nevertheless,  after  this  substantial  increase 
in glucose levels onion administration significantly 
reduced the blood glucose levels to a point below 
that  produced  in  the  negative  control  group  after 
4 hours (Table 4; Fig. 4). The oral administration of 
glibenclamide (5 mg) showed a significant reduction 
in the induced hyperglycemia in the participants of 
the  positive  control  subgroup  by  157  mg/dl  after 
4 hours, compared to water, since it is known to act 
by direct induction of insulin release from the pan-
creatic beta cells.16
The  observed  increase  in  fasting  blood  glucose 
levels in all subgroups during the first hour and after 
ingestion of Allium cepa (Tables 1 and 3) which attrib-
uted to its glucogenic effects of Allium cepa20,21 can 
counteract the common side effect (hypoglycemia) 
of antidiabetic agents currently used if Allium cepa 
is taken concurrently as food supplement and as pre-
sented in previous studies cysteine present in Allium 
cepa could be the main cause of the glucogenic effects 
of onion.19,21
Although the number of participants in the study 
groups  is  small  to  reach  concrete  conclusions, 
Allium cepa in addition to its nutritional values has 
hypoglycemic  effects  that  could  be  beneficial  in 
management of type 1 and type 2 diabetic patients 
of all age groups, especially the level of its safety as 
reflected by its worldwide use as vegetable.
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